A New Hope for Advanced Pancreatic Cancer: Daraxonrasib Shows Remarkable Results
Pancreatic cancer is still one of the toughest cancers to treat. Once the disease starts growing again after the first round of treatment, the options become limited, and the outlook is often discouraging. For years, second-line treatments have helped only a little, leaving both patients and doctors hoping for